1Dinarello CA,Gelfand JA,Wolff SM.Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. The Journal of The American Medical Association . 1993
2Estrov Z,Kurzrock R,Wetzler M et al.Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood . 1991
3Antin JH,Weinstein HJ,Guinan EC,et al.Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood . 1994
4Estrov Z,Kurzrock R,Talpaz M.Cytokines and their antagonists in myeloid disorders. Seminars in Hematology . 1995
5Anklesaria P,Teixido’J,Laiho M et al.Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor-alpha to epidermal growth factor receptors promotes cell proliferation. Proceedings of the National Academy of Sciences of the United States of America . 1990
6Rose-John S,Heinrich PC.Soluble receptors for cytokines and growth factors: generation and biological function. Biochemical Journal . 1994
7Suzu S,Ohtsuki T,Makishima M et al.Biological activity of a proteoglycan form of macrophage colony-stimulating factor, and its binding to type V collagen. Journal of Biological Chemistry . 1992
8Fisher CJ,Dhainaut J-FA,Opal SM et al.Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. The Journal of The American Medical Association . 1994
9Diez-Ruiz A,Tilz GP,Zangerle R et al.Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. European Journal of Haematology . 1995
10Mohler KM,Torrance DS,Smith CA.Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol . 1993
